Trial Details

COMPLETED
Basic Information
Clinical ID c1097
Identifier NCT04499495
Trial Title Assessment of 5-Aminosalicylic Acid Prescription Patterns and Treatment Outcomes in Patients With Ulcerative Colitis in Korea
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions OTHER: PENTASA (mesalamine/ 5-Aminosalicylic acid (5-ASA)
Participant Information
Sponsor Ferring Pharmaceuticals
City Seoul
Country/Region Korea, Republic of
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2021-10-25
Primary Completion Date 2022-07-31
Completion Date 2022-07-31